Interventional & Structural Cardiologist @KPcolorado | @CookCtyHealth @RushGradCollege Alumni | Tweets are my own ≠ medical advice.
Joined May 2010
- Tweets 613
- Following 1,019
- Followers 1,210
- Likes 3,969
32 Photos and videos
Fady Iskander MD, MSc retweeted
Jun 1
This State-of-the-Art review provides a comprehensive and practical overview of coronary interventions related to TAVI, encompassing coronary evaluation and physiological assessment, the indications and timing of percutaneous coronary intervention before and after valve implantation, and strategies for managing coronary obstruction. eurointervention.pcronline.c…
82
184
12,499
Fady Iskander MD, MSc retweeted
Mar 24
21,888
101,215
453,806
34,104,682
Fady Iskander MD, MSc retweeted
1/8
🚨 The results of CLOSURE-AF are in, providing a sobering look at Left Atrial Appendage Closure (LAAC).
This was the first trial to test the device against modern DOAC therapy in the high-risk patients seen in daily practice.
The verdict: LAAC failed to meet non-inferiority
6
42
133
13,980
Fady Iskander MD, MSc retweeted
Feb 24
JUST OUT #JACCINT @JACCJournals . SOTA comprehensive review on #PVL diagnosis and management post #TAVR.
jacc.org/doi/full/10.1016/j.…
11
48
3,464
Fady Iskander MD, MSc retweeted
Feb 24
JUST OUT! Our official "Double-tap" Sapien 3 Ultra Resilia #TAVR paper is here #JACCINT @JACCJournals, showing double-tap post-dilatation optimizes S3UR expansion on fluoro. This has now become standard practice @MountSinaiHeart and many centers worldwide! Nice editorial by @ronwaksman and Viewpoints by the #Vancouver group!
jacc.org/doi/10.1016/j.jcin.…
jacc.org/doi/10.1016/j.jcin.…
jacc.org/doi/10.1016/j.jcin.…
@MountSinaiNYC
@IcahnMountSinai
@ParasuramMD
@DoctorKini
@KHERA_MD
@LucySafi
@sunnygoelmd
@AmithoodaMD
@georgedangas
@DrDavidReich
@Dr_BrendanCarr
@DLBHATTMD
3
21
86
13,381
Fady Iskander MD, MSc retweeted
Feb 16
6 yrs after surgery or #TAVR with CoreValve/Evolut, low-risk AS pts showed no difference in all-cause mortality or disabling #stroke in the Evolut Low-Risk trial. However, reinterventions were higher after TAVR, largely driven by increased AR. jacc.org/doi/10.1016/j.jacc.… #JACC
49
140
80,027
Fady Iskander MD, MSc retweeted
Feb 11
JUST OUT #JACCINT @JACCJournals ! Our Redo #TAVR concept and planning simplified. Coronary Risk Zone (CRZ) denotes the zone that you MUST measure the valve to coronary/aorta/STJ distance to assess coronary obstruction risk. The minimal distance is what matter most. Great work by @OleDeBacker @bapat_savrtavr @Miho_Fukui_ @SyedZaid to help move this field forward!
jacc.org/doi/10.1016/j.jcin.…
5
84
269
17,817
Fady Iskander MD, MSc retweeted
Bicuspid is no longer a niche.
In this SOTA, @didier_tchetche et al walk through TAVI in BAV: phenotypes, CT sizing (BAVARD, circle, CASPER), procedural tricks, long-term concerns and the need for TAVI vs SAVR RCTs.
Don't miss it 👉eurointervention.pcronline.c…
#TAVI #cardiotwitter #CardioX #CardioEd
@YWillemen
@Vinscesario
3
45
114
9,649
Fady Iskander MD, MSc retweeted
IV #thrombolysis 4.5–24h post-stroke improves outcomes but increases sICH risk.
Tenecteplase ≈ Alteplase, with less bleeding trend.
#Stroke @amirghabousian @AlimoradiMD @fady_iskander @azeemlatib @ToshikiKuno @RamchandPreethi
ahajournals.org/doi/10.1161/…
4
12
863
Fady Iskander MD, MSc retweeted
22 Jul 2025
Transapical UNICORN to facilitate valve in valve TAVR.
@MCWcardiology
onlinelibrary.wiley.com/shar…
5
21
1,205
Fady Iskander MD, MSc retweeted
3 Nov 2025
Transcatheter Valve Replacement in Adults with Congenital Heart Disease. Is there limited prothesis longevity in this patient population? @EleidMack @Dr_JHAnderson ahajrnls.org/4nB5mzo
1
6
28
3,300
Fady Iskander MD, MSc retweeted
16 Oct 2025
Fresh update on cardiovascular salaries.
5
5
104
30,204
3 Oct 2025
AVP II placement for severe PVL with successful reduction to trivial PVL.
#CMPG structural heart
1
11
636
Fady Iskander MD, MSc retweeted
12 Sep 2025
Sub-analysis of the BEST trial showing IVUS-guided PCI equivalent to CABG!
An excellent review of the paper by @GreggWStone discussed how we can be better at what we do and be equivalent to bypass.
In the order of importance, just in my opinion!
1-Intravscular imaging. A must, not an option. Needs meaningful use not just "use"
2-Complete revascularization- I am a huge believer. Complete the job
3-Physiology! will leave it to physiology enthusiasts :D
heart.bmj.com/content/111/19…
heart.bmj.com/content/111/19…
#cardioX
6
52
151
14,034
Fady Iskander MD, MSc retweeted
6 Sep 2025
The OPTION-STEMI trial, presented at #ESCCongress2025, investigated the timing of complete revascularization in patients with STEMI and multivessel disease.
🥸 See below for some contrast with the SLIM clinical trial (note cohorts are STEMI vs. NSTEMI)
😱see below
👇👇👇
6 Sep 2025
Fractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel Disease: @JAMANetwork
🥸 FFR guided complete revascularization during index procedure: Contradicts the recent OPTION STEMI trial data
😱 GM 👇
1
20
82
23,643
Fady Iskander MD, MSc retweeted
31 Aug 2025
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction: @NEJM
🥸 Will the use of Aspirin decline overtime in ACS management? #ESCCongress2025
😱The TARGET-FIRST trial
👇👇👇
1
42
214
25,639
Fady Iskander MD, MSc retweeted
29 Aug 2025
2025 ESC/EACTS Guidelines for the
management of valvular heart disease: @ESC_Journals
🥸Few highlights - dense document, please read full document for details.
😱 Summary
👇👇👇
5
132
512
61,241
Fady Iskander MD, MSc retweeted
29 Aug 2025
The 2025 ESC/EACTS guidelines on the management of valvular heart disease have just been released, with an important update: the age threshold for the Heart Team to consider TAVI instead of surgical intervention has been lowered from 75 to 70 years in patients with tricuspid aortic valve anatomy deemed suitable. #ESCCongress academic.oup.com/eurheartj/a…
6
90
206
24,362